maltol has been researched along with Dementia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JH; Kim, HJ; Kim, HS; Kim, S; Lee, GH; Lee, HG; Lee, KS; Park, CH; Park, SH; Shin, KY; Suh, YH; Won, BY | 1 |
1 other study(ies) available for maltol and Dementia
Article | Year |
---|---|
A novel compound, maltolyl p-coumarate, attenuates cognitive deficits and shows neuroprotective effects in vitro and in vivo dementia models.
Topics: Amyloid beta-Peptides; Animals; Apoptosis; Blotting, Western; Caspase 3; Cognition; Coumaric Acids; Cytochromes c; Dementia; Disease Models, Animal; Enzyme Activation; In Situ Nick-End Labeling; Muscarinic Antagonists; Neuroprotective Agents; Pyrones; Rats; Rats, Wistar; Reactive Oxygen Species; Scopolamine | 2007 |